Paper
0
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)
Authors
Ghayas Issa,Ibrahim Aldoss
Michael Thirman,John DiPersio,Martha Arellano,James Blachly,Gabriel Mannis,Alexander Perl,David Dickens,Christine McMahon,Elie Traer,C. Zwaan,Carolyn Grove,Richard Stone,Paul Shami,Ioannis Mantzaris,Matthew Greenwood,Neerav Shukla,Branko Cuglievan,Tibor Kovacsovics,Yu Gu,Rebecca Bagley,Kate Madigan,Yakov Chudnovsky,Nguyễn Huy,Nicole McNeer,Eytan Stein,Andrew Wei,Shaun Fleming,Himalee Sabins,Manish Patel,Chetasi Talati,Jing Chen,Boaz Nachmias,Maël Heiblig,Pablo Fernández,Montserrat Arnan-Sangerman,Ofir Wolach,Giovanni Marconi,Ashish Bajel,Andre Schuh,John Byrd
+40 authors
,James WhitlockJournal
Published
Aug 9, 2024
Show more
Save
Tip0
TipSave